UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Access to cannabidiol without a prescription: A cross-country comparison and analysis

The International journal of drug policy, 2020-11, Vol.85, p.102935-102935, Article 102935

2020

Volltextzugriff (PDF)

Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation

Molecules (Basel, Switzerland), 2020-01, Vol.25 (2), p.417

2020

Volltextzugriff (PDF)

Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

Frontiers in pharmacology, 2022-05, Vol.13, p.885655-885655

2022

Volltextzugriff (PDF)

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing

Frontiers in pharmacology, 2023-06, Vol.14, p.1142680-1142680

2023

Volltextzugriff (PDF)

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

Frontiers in psychiatry, 2022-12, Vol.13, p.1048836-1048836

2022

Volltextzugriff (PDF)

The Endocannabinoid System as a Therapeutic Target in Glaucoma

Neural plasticity, 2016-01, Vol.2016 (2016), p.1-10

2016

Volltextzugriff (PDF)

Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs

Frontiers in psychiatry, 2022-09, Vol.13, p.1010501

2022

Volltextzugriff (PDF)

Medicinal cannabis in the treatment of chronic pain

Australian journal of general practice, 2021-10, Vol.50 (10), p.724-732

2021

Volltextzugriff (PDF)

Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model

Neuropharmacology, 2019-06, Vol.151, p.1-12

2019

Volltextzugriff (PDF)

Why support a separate medical access framework for cannabis?

Canadian Medical Association journal (CMAJ), 2017-07, Vol.189 (28), p.E927-E928

2017

Volltextzugriff (PDF)

Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA

ACS chemical neuroscience, 2024-05, Vol.15 (9), p.1787-1812

2024

Volltextzugriff (PDF)

Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA

RSC medicinal chemistry, 2024-06, Vol.15 (6), p.263-279

2024

Volltextzugriff (PDF)

Cannabichromene and Δ 9 -Tetrahydrocannabinolic Acid Identified as Lactate Dehydrogenase-A Inhibitors by in Silico and in Vitro Screening

Journal of natural products (Washington, D.C.), 2021-05, Vol.84 (5), p.1469-1477

2021

Volltextzugriff (PDF)

Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA

ACS chemical neuroscience, 2023-01, Vol.14 (1), p.35-52

2023

Volltextzugriff (PDF)

Structure-activity relationships of valine, tert -leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA

RSC medicinal chemistry, 2022-02, Vol.13 (2), p.156-174

2022

Volltextzugriff (PDF)

Structure–Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA

ACS chemical neuroscience, 2024-05, Vol.15 (11), p.2160-2181

2024

Volltextzugriff (PDF)

NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?

ACS chemical neuroscience, 2021-11, Vol.12 (21), p.4020-4036

2021

Volltextzugriff (PDF)

Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T‑Type Calcium Channel (CaV3) Inhibitors

ACS chemical neuroscience, 2022-05, Vol.13 (9), p.1395-1409

2022

Volltextzugriff (PDF)

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB 1 receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB 1 receptors

Drug testing and analysis, 2021-07, Vol.13 (7), p.1383-1401

2021

Volltextzugriff (PDF)

The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy

Neuropharmacology, 2013-09, Vol.72, p.116-125

2013

Volltextzugriff (PDF)

Paleomagnetic evidence for vertical-axis rotations of crustal blocks in the Woodlark Rift, SE Papua New Guinea: Miocene to present-day kinematics in one of the world's most rapidly extending plate boundary zones

Geochemistry, geophysics, geosystems : G3, 2015-07, Vol.16 (7), p.2058-2081

2015

Volltextzugriff (PDF)

Seeing over the horizon – targeting the endocannabinoid system for the treatment of ocular disease

Journal of basic and clinical physiology and pharmacology, 2016-05, Vol.27 (3), p.253-265

2016

Volltextzugriff (PDF)

The In Vivo Effects of the CB 1 -Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice

Journal of ocular pharmacology and therapeutics, 2017-10, Vol.33 (8), p.582-590

2017

Volltextzugriff (PDF)

The Cannabinoids Δ 8 THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation

Cannabis and cannabinoid research, 2018-05, Vol.3 (1), p.11-20

2018

Volltextzugriff (PDF)

The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation

Cannabis and cannabinoid research, 2018-02, Vol.3 (1), p.11-20

2018

Volltextzugriff (PDF)

1 – 25 von 260

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(217)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Access to cannabidiol without a prescription: A cross-country comparison and analysis

Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation

Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

The Endocannabinoid System as a Therapeutic Target in Glaucoma

Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs

Medicinal cannabis in the treatment of chronic pain

Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model

Why support a separate medical access framework for cannabis?

Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA

Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA

Cannabichromene and Δ 9 -Tetrahydrocannabinolic Acid Identified as Lactate Dehydrogenase-A Inhibitors by in Silico and in Vitro Screening

Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA

Structure-activity relationships of valine, tert -leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA

Structure–Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA

NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?

Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T‑Type Calcium Channel (CaV3) Inhibitors

The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy

Paleomagnetic evidence for vertical-axis rotations of crustal blocks in the Woodlark Rift, SE Papua New Guinea: Miocene to present-day kinematics in one of the world's most rapidly extending plate boundary zones

Seeing over the horizon – targeting the endocannabinoid system for the treatment of ocular disease

The In Vivo Effects of the CB 1 -Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice

The Cannabinoids Δ 8 THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation

The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation

Suchergebnisse filtern